Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Suzuken Co ( (JP:9987) ) is now available.
Suzuken Co., Ltd. announced the results of its recent share repurchase program, acquiring 195,500 common shares for approximately ¥1.15 billion between November 1 and November 19, 2025. This move is part of a broader strategy to repurchase up to 5.2 million shares by March 2026, aiming to enhance shareholder value and optimize capital structure.
The most recent analyst rating on (JP:9987) stock is a Buy with a Yen6800.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the healthcare industry, primarily focusing on the distribution of pharmaceuticals and medical devices. The company is listed on the Tokyo, Nagoya, and Sapporo Stock Exchanges, indicating a strong market presence in Japan.
Average Trading Volume: 180,178
Technical Sentiment Signal: Buy
Current Market Cap: Yen338.5B
For a thorough assessment of 9987 stock, go to TipRanks’ Stock Analysis page.